Dongyang Xu (@dongyangxu1) 's Twitter Profile
Dongyang Xu

@dongyangxu1

ID: 829190342

calendar_today17-09-2012 14:40:44

126 Tweet

22 Followers

172 Following

JACC Journals (@jaccjournals) 's Twitter Profile Photo

New #JACC study tests the hypothesis that #cvMI impairs leaflet growth seen in #vhdAR and induces fibrotic changes in mitral and tricuspid valves. bit.ly/2RSneJj

New #JACC study tests the hypothesis that #cvMI impairs leaflet growth seen in #vhdAR and induces fibrotic changes in mitral and tricuspid valves. bit.ly/2RSneJj
Lena E. Trager, MD (@lenaetrager) 's Twitter Profile Photo

Check out our new pub from the Rosenzweig lab: Targeting Age-Related Pathways in Heart Failure | Circulation Research. Just in time for Valentine's day ❤️! ahajournals.org/doi/10.1161/CI… Circulation Research Circulation Mass General Heart #benchtobedside #heartfailure

Check out our new pub from the Rosenzweig lab:
Targeting Age-Related Pathways in Heart Failure | Circulation Research. Just in time for Valentine's day ❤️! ahajournals.org/doi/10.1161/CI… <a href="/CircRes/">Circulation Research</a> <a href="/CircAHA/">Circulation</a> <a href="/MGHHeartHealth/">Mass General Heart</a> #benchtobedside #heartfailure
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Despite medical therapy and primary #PCI in #STEMI, nearly 50% of patients experience left ventricular post-infarct remodeling, which is subsequently linked with ⬆️ risks of #heartfailure. bit.ly/31QUlBX #JACCHF

Despite medical therapy and primary #PCI in #STEMI, nearly 50% of patients experience left ventricular post-infarct remodeling, which is subsequently linked with ⬆️  risks of #heartfailure. bit.ly/31QUlBX #JACCHF
Nature Reviews Cardiology (@natrevcardiol) 's Twitter Profile Photo

New #Review online: mechanisms underlying the development of diabetic cardiomyopathy and heart failure by Lu Cai and colleagues | rdcu.be/b1Zc9 UofL Medicine #diabetes #diabeticcardiomyopathy

New #Review online: mechanisms underlying the development of diabetic cardiomyopathy and heart failure by Lu Cai and colleagues | rdcu.be/b1Zc9

<a href="/UofLMedicine/">UofL Medicine</a> #diabetes #diabeticcardiomyopathy
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

Exciting new analyses from COAPT by Milton Packer & Paul Grayburn support validity of proportionate and disproportionate MR in #heartfailure ja.ma/39OtVnb

RyanSwag (@swgtips) 's Twitter Profile Photo

Master League 101 👉👉youtu.be/uzV6eVVBBOQ Welcome to the Master League. This lesson will cover: 🏆The Best Picks ♻️The Rock-Paper-Scissors of the meta 🙋‍♀️Team Building Tips 📊Key PvP Resources #PokemonGO #GOBattle

Master League 101
👉👉youtu.be/uzV6eVVBBOQ

Welcome to the Master League. 
This lesson will cover:

🏆The Best Picks

♻️The Rock-Paper-Scissors of the meta

🙋‍♀️Team Building Tips

📊Key PvP Resources
#PokemonGO #GOBattle
Dongyang Xu (@dongyangxu1) 's Twitter Profile Photo

12U giratina DUO in windy. We cant get 2 teams of 6 and not be dead at the same time cuz we maxed different pokemon. So my partner has a 5 member team. So its strictly speaking 11 unique?Lol Kaito Nolan

NBA History (@nbahistory) 's Twitter Profile Photo

Michael Jordan - most PTS in the 4th quarter of a Finals game: 16 - G6 1998 at UTH 15 - G6 1997 vs UTH 14 - G1 1993 at PHX Watch Jordan save his best for last on #NBATogetherLive. #Game6Live x.com/i/broadcasts/1…

Valva Mitralis (@mitrovalvology) 's Twitter Profile Photo

Utilization of Engineering Advances for Detailed Biomechanical Characterization of the Mitral–Ventricular Relationship to Optimize Repair Strategies: A Comprehensive Review mdpi.com/2298358 #mdpibioengineering via MDPI

JACC Journals (@jaccjournals) 's Twitter Profile Photo

The JenaValve! The first transfemoral on-label #TAVR system for the treatment of #AR! A multicenter registry of 58 patients reports device success in 98% with a 30-day mortality rate of 1.7% bit.ly/3qMUZkV (3/5)

The JenaValve! The first transfemoral on-label #TAVR system for the treatment of #AR! A multicenter registry of 58 patients reports device success in 98% with a 30-day mortality rate of 1.7% bit.ly/3qMUZkV

(3/5)